Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic™ Endovascular System
Boston Scientific Corporation (NYSE: BSX) has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT).